期刊文献+

夜发性额叶癫痫三家系临床和遗传学特征 被引量:1

Clinical and genetic studies in three families with nocturnal frontal lobe epilepsy
原文传递
导出
摘要 目的分析夜发性额叶癫痫3个家系的临床、脑电图和遗传学特征。方法在3个夜发性额叶癫痫家系患者及部分亲属中收集临床、脑电图及神经影像学等资料,并采用测序方法筛查烟碱型乙酰胆碱受体(nAChR)讲、132和以亚单位编码基因(CHRNA4、CHRNB2和CHRNA2)。结果3个家系中有6例患者(其中男5例),平均年龄(20.5±11.5)岁,平均发病年龄(7.3±5.5)岁,临床表现为夜发性额叶发作,具体发作类型包括姿势性发作2例,躯体自动症发作4例,最多每夜发作6次。发作间期、发作期视频脑电图2例患者表现为正常或动作伪差,2例表现为前部导联慢波节律,3例出现前部导联棘波、棘慢波及尖波。神经系统及神经影像检查未见异常。抗癫痫药物治疗反应良好。CHRNA4、CHRNB2和CHRNA2部分序列(包含跨膜区1~3)筛查未见突变。结论夜发性额叶癫痫是一种遗传异质性癫痫综合征。 Objective To investigate the clinical, electroencephalogram (EEG) and genetic features of nocturnal frontal lobe epilepsy (NFLE) in the Chinese population. Methods Clinical examination, EEG recording, mutation screenings in transmembrane domains 1-3 of neuronal nicotinic acetylcholine receptor (nAChR) α4 ( CHRNA4 ), 132 ( CHRNB2 ) and α2 ( CHRNA2 ) using PCR amplification and sequencing were carried out on 6 patients and some members in 3 families with NFLE. Results Among 6 patients (5 male) with NFLE, the mean age was (20.5± 11.5) years and the mean age at onset was (7.3±5.5 ) years. Clinical features included seizures of dystonic posturing in 2 patients and seizures of hyperkinetic movements in 4 patients with the maximum frequency of 6 seizures within one night. The ictal and interictal video-EEG (VEEG) of frontal lobes showed epileptic discharges, slow wave activity, normal activity or electrode artifacts. There weren' t abnormity in other clinical examination and neuroimagings. No mutations were identified in the genes screened. Conclusion NFLE is a heterogenetic epilepsy syndrome.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2009年第6期386-389,共4页 Chinese Journal of Neurology
关键词 癫痫 额叶 系谱 受体 烟碱 脑电描记术 Epilepsy, frontal lobe Pedigree Receptors, nicotinic Electroencephalography
  • 相关文献

参考文献19

  • 1Engel J Jr.Report of the ILAE classification core group.Epilepsia,2006,47:1558-1568.
  • 2Engel J Jr;International League Against Epilepsy (ILAE).A proposed diagnostic scheme for people with epileptic seizures and with epilepsy:report of the ILAE Task Force on Classification and Terminology.Epilepsia,2001,42:796-803.
  • 3Seheffer IE,Bhatia KP,Lopes-Cendes I,et al.Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder.Lancet,1994,343:515-517.
  • 4Combi R,Dalpra L,Tenchini ML,et al.Autosemal dominant nocturnal frontal lobe epilepsy--a critical overview.J Neurol,2004,251:923-934.
  • 5Ryvlin P,Rheims S,Risse G.Nocturnal frontal lobe epilepsy.Epilepsia,2006,47 Suppl 2:83-86.
  • 6Provini F,Plazzi G,Tinuper P,et al.Nocturnal frontal lobe epilepsy.A clinical and polygraphic overview of 100 consecutive cases.Brain,1999,122:1017-1031.
  • 7Aridon P,Marini C,Di Resta C,et al.Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear.Am J Hum Ganet,2006,79:342-350.
  • 8Di Corcia G,Blasetti A,De Simone M,et al.Recent advances on autosomal dominant nocturnal frontal lobe epilepsy:" understanding the nicotinic acetylcholine receptor (nAChR)".Eur J Paediatr Neurol,2005,9:59-66.
  • 9Leniger T,Karumura C,Hufnagel A,et al.A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy.Epilepsia,2003,44:981-985.
  • 10Hoda JC,Gu W,Friedli M,et al.Human nocturnal frontal lobe epilepsy:pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore.Mol Pharmacol,2008,74:379-391.

二级参考文献7

  • 1Thompson HM, Cao H, Chen J, et al. Dynamin 2 binds gammatubulin and participates in centrosome cohesion. Nat Cell Biol, 2004, 6:335-342.
  • 2North K. Congenital myopathies//Engel AG, Franzini-Armstrong C. 3rd ed. New York: McGraw-Hill, 2004: 1490-1495.
  • 3Spiro AJ, Shy GM, Gonatas NK. Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch Neurol, 1966, 14: 1-14.
  • 4Laporte J, Hu LJ, Kretz C, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet, 1996, 13: 175-182.
  • 5Bitoun M, Maugenre S, Jeannet PY, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet, 2005, 37 : 1207 -1209.
  • 6Jeannet PY, Bassez G, Eymard B, et al. Clinical and histologic findings in autosomal centronuclear myopathy. Neurology, 2004, 62 : 1484-1490.
  • 7Zuchner S, Noureddine M, Kennerson M, et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet, 2005, 37: 289-294.

共引文献7

同被引文献41

  • 1Gonzalez MI. The possible role of GABAA receptors and gephyrin in epileptogenesis. Front Cell Neurosci, 2013, 7:113.
  • 2Cho CH. New mechanism for glutamate hypothesis in epilepsy. Front Cell Neurosci, 2013, 7:127.
  • 3Xu J, Cohen BN, Zhu YL, Dziewczapolski G, Panda S, Lester HA, Heinemann SF, Contractor A. Altered activity-rest patterns in mice with a human autosomal- dominant nocturnal frontal lobe epilepsy mutation in the β 2 nicotinic receptor. Mol Psychiatry, 2011, 16:1048-1061.
  • 4O'Neill HC, Laverty DC, Patzlaff NE, Cohen BN, Fonck C, McKinney S, Mclntosh JM, Lindstrom JM, Lester HA, Grady SR, Marks MJ. Mice expressing the ADNFLE valine 287 leucine mutation of the B2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function. Pharmacol Biochem Behav, 2013, 103:603-621.
  • 5Martinez A, Finegersh A, Cannon DM, Dustin I, Nugent A, Herscovitch P, Theodore WH. The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy. Neurology, 2013, 80:1465- 1471.
  • 6Boison D, Chen JF, Fredholm BB. Adenosine signalling and function in glial cells. Cell Death Differ, 2010, 17:1071-1082.
  • 7Boison D. Adenosine dysfunction in epilepsy. Glia, 2012, 60: 1234-1243.
  • 8Luan G, Gao Q, Guan Y, Zhai F, Zhou J, Liu C, Chen Y, Yao K, Qi X, Li T. Upregulation of adenosine kinase in Rasmussen encephalitis. Neuropathol Exp Neurol, 2013, 72:1000-1008.
  • 9Zamponi GW, Lory P, Perez-Reyes E. Role of voltage-gated calcium channels in epilepsy. Pflugers Arch, 2010, 460:395- 403.
  • 10de Lanerolle NC, Lee TS, Spencer DD Neurotherapeutics, 2010, 7:424-438.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部